Content about HIV

December 21, 2011
Merck's Isentress approved for children, adolescents

The Food and Drug Administration has approved an HIV drug for children and adolescents, the agency said Wednesday.

December 20, 2011
WHO approves Mylan generic HIV drugs for use in developing world

The World Health Organization has approved three generic second-line treatments for HIV made by Mylan, the drug maker said Tuesday. The drugs will be delivered to people in developing countries living with HIV and AIDS.

December 16, 2011
STDs becoming more prevalent across baby boomer demographic

According to an article in the November/December issue of the journal Medical-Surgical Nursing, rates of HIV/AIDS, herpes, syphilis, human papilloma virus and other STDs are climbing steadily across men and women older than 50 years.

December 15, 2011
FDA to review patch for HIV-related pain

A Food and Drug Administration expert panel will review a drug made by NeurogesX as a potential treatment for pain associated with HIV.

December 5, 2011
On the brink of Clinics 2.0

Since the inception of retail-based health clinics in 2000, the concept has grown to more than 1,300 locations throughout the United States. The real question now: Are we on the brink of clinics version 2.0?


November 11, 2011
Study: Retail-based clinics a viable business for Walmart, other retailers, if managed correctly

Retail-based health clinics represent a viable business for retailers who locate and correctly manage them, according to Kalorama Information.

November 10, 2011
Walgreens fields 500-plus HIV Centers of Excellence pharmacies

Walgreens now has certified more than 500 of its pharmacies as HIV Centers of Excellence in communities highly impacted by HIV, as identified by the Centers for Disease Control and Prevention, the pharmacy operator announced Thursday at the U.S. Conference on AIDS.

November 8, 2011
FDA develops Web resource outlining proper sharps disposal

The Food and Drug Administration on Tuesday launched a website for patients and caregivers on the safe disposal of needles and other “sharps” that are used at home, at work and while traveling.

November 7, 2011
Walgreens joins Magic Johnson Foundation on Point Forward Day

The Magic Johnson Foundation on Monday initiated Point Forward Day, marking 20 years to the date that Johnson announced his HIV status and subsequent retirement from the National Basketball Association.

October 27, 2011
Bristol-Myers Squibb, Gilead Sciences to develop, commercialize HIV combo treatment

Drug makers Bristol-Myers Squibb and Gilead Sciences announced an agreement to develop and commercialize a fixed-dose combination treatment for patients with HIV.

September 22, 2011
J&J HIV drug shows fewer side effects in trial data analysis

A new study has found that a recently approved drug for HIV produces fewer unpleasant side effects during the first three months of therapy than the standard treatment, according to published reports.

September 20, 2011
Under PEPFAR, Matrix granted tentative approval for novel co-packaged HIV/AIDS treatment

Mylan subsidiary Matrix Labs has received tentative approval from the Food and Drug Administration for its new drug application of a co-packaged antiretroviral treatment under the President's Emergency Plan for AIDS Relief.

September 19, 2011
Merck drug for HIV effective, tolerated, study results show

A drug made by Merck for treating HIV infection was effective and tolerated in patients regardless of their gender or race, according to results of a late-stage clinical trial announced Monday.

August 24, 2011
Q&A: A new twist 
on specialty Rx

Specialty pharmacy is expanding beyond its traditional base as a central-fill and mail-order distribution model for patients. A new, community-driven model is emerging, led by a fast-growing network of integrated, 
community-based specialty providers based in Drexel Hill, Pa.

August 16, 2011
Events to raise awareness of AIDS, healthcare initiatives

The Community Education Group and the Urban Coalition for HIV/AIDS Prevention Services will sponsor a series of community mobilizing events around the country in the time leading up to the International AIDS Conference in Washington next July.

August 11, 2011
FDA approves single-pill HIV drug

The Food and Drug Administration has approved a new single-pill treatment for HIV made by Gilead Sciences and Johnson & Johnson, Gilead said.

August 8, 2011
Pharmacy professor to assist in review of ReachRx protocols and initiatives for Armada

Specialty pharmacy services company Armada Health Care has enlisted a New York pharmacy professor to assist in the review of developed clinical protocols and medication assessment tools, Armada said Monday.

July 19, 2011
Matrix expands licensing agreement with Gilead for HIV/AIDS therapies

Mylan subsidiary Matrix Labs has expanded its licensing agreement with Gilead Sciences.

July 19, 2011
Ranbaxy to produce, market antiretrovirals under licensing agreement with Gilead

Ranbaxy will produce and market three HIV/AIDS drugs that currently are in late-stage clinical development by Gilead under a new licensing agreement between the drug makers.

July 18, 2011
Minimal drug interaction found between Livalo, HIV drugs

A statin made by Eli Lilly and Kowa Pharmaceuticals America appears to work well with drugs used to treat HIV, according to a study presented at the sixth International AIDS Society conference on HIV Pathogenesis, Treatment and Prevention in Rome.

July 14, 2011
Merck partners with universities to research ways to eradicate HIV

A team comprised of scientists from drug maker Merck and several U.S. universities will look for ways to eradicate HIV, Merck said.

July 13, 2011
Studies find HIV drug treatments may reduce infection risk among heterosexual couples

Taking drugs for treating HIV might reduce the risk of infection among heterosexual couples, according to two new studies conducted in Africa.

June 30, 2011
Physicians urge FDA not to approve Truvada

A group of physicians is urging the Food and Drug Administration not to approve a drug made by Gilead Sciences for the prevention of HIV infection.

June 28, 2011
Gilead, Tibotec to develop HIV drug

A subsidiary of Johnson & Johnson and Gilead Sciences will collaborate to develop a combination drug for HIV, the two companies said Tuesday.

June 22, 2011
Walgreens, Ebony encourage Americans to be 'Greater Than AIDS'

Walgreens has teamed with Greater Than AIDS, a national campaign in response to HIV/AIDS in the United States, to distribute informational resources and specialized HIV-related services at more than 300 Walgreens pharmacies in heavily affected communities, the Kaiser Family Foundation announced Tuesday.

© 2013 Drug Store News. All Rights Reserved.